Evaluation of the Effect of Telmisartan (Micardis® 80 mg/ MicardisPlus® 80/12.5 mg) on Blood Pressure and Cardiovascular Risk Factor Index in High Risk Hypertensive Patients

Boehringer Ingelheim Investigational Site 24, Brežice

Boehringer Ingelheim Investigational Site 2, Brežice

Boehringer Ingelheim Investigational Site 12, Celje

Boehringer Ingelheim Investigational Site 16, Celje

Boehringer Ingelheim Investigational Site 17, Celje

Boehringer Ingelheim Investigational Site 1, Celje

Boehringer Ingelheim Investigational Site 33, Celje

Boehringer Ingelheim Investigational Site 18, Golnik

Boehringer Ingelheim Investigational Site 23, Golnik

Boehringer Ingelheim Investigational Site 29, Golnik

Boehringer Ingelheim Investigational Site 32, Golnik

Boehringer Ingelheim Investigational Site 15, Jesenice

Boehringer Ingelheim Investigational Site 4, Kranj

Boehringer Ingelheim Investigational Site 28, Litija

Boehringer Ingelheim Investigational Site 26, Ljubljana

Boehringer Ingelheim Investigational Site 35, Ljubljana

Boehringer Ingelheim Investigational Site 3, Ljubljana

Boehringer Ingelheim Investigational Site 6, Ljubljana

Boehringer Ingelheim Investigational Site 14, Maribor

Boehringer Ingelheim Investigational Site 22, Maribor

Boehringer Ingelheim Investigational Site 20, Murska Sobota

Boehringer Ingelheim Investigational Site 27, Murska Sobota

Boehringer Ingelheim Investigational Site 31, Murska Sobota

Boehringer Ingelheim Investigational Site 11, Novo Mesto

Boehringer Ingelheim Investigational Site 19, Novo Mesto

Boehringer Ingelheim Investigational Site 21, Novo Mesto

Boehringer Ingelheim Investigational Site 9, Novo Mesto

Boehringer Ingelheim Investigational Site 25, Sempeter

Boehringer Ingelheim Investigational Site 30, Sempeter

Boehringer Ingelheim Investigational Site 34, Sežana

Boehringer Ingelheim Investigational Site 10, Slovenj Gradec

Boehringer Ingelheim Investigational Site 36, Slovenj Gradec

Boehringer Ingelheim Investigational Site 13, Topolšica

Boehringer Ingelheim Investigational Site 5, Trbovlje

Boehringer Ingelheim Investigational Site 8, Trbovlje

Boehringer Ingelheim Investigational Site 7, Velenje